Stay at the forefront of the week’s champions and runners-up among publicly traded biotech companies and the reasons behind the ups or downs of their stock price fluctuations.

StockWatch appears weekly in GEN Edge. Subscribe today to GEN Edge, starting with our 30-Day Free Trial, and keep a leading edge on the competition.

Biogen (BIIB)’s second cost-cutting restructuring in five months . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge